Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus-Type 1”

Showing 20 of 0 results

Very early researchActive Not RecruitingNCT03729778
What this trial is testing

Impact of HIV-1 and Aging on Mucosal Vaccine Responses

Who this might be right for
HIV-1-infectionHuman Immunodeficiency VirusHIV/AIDS+1 more
VA Eastern Colorado Health Care System 100
Large-scale testing (Phase 3)Study completedNCT00543725
What this trial is testing

TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors

Who this might be right for
HIV InfectionsHIV-1
Tibotec Pharmaceuticals, Ireland 680
Not applicableEnded earlyNCT00340548
What this trial is testing

Host Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort (HGDS-3)

Who this might be right for
HemophiliaAIDS
National Cancer Institute (NCI) 333
Not applicableStudy completedNCT01539226
What this trial is testing

Safety and Efficacy Trial of a Dapivirine Vaginal Matrix Ring in Healthy HIV-Negative Women

Who this might be right for
HIV Infections
International Partnership for Microbicides, Inc. 1,959
Post-approval studies (Phase 4)Study completedNCT03512210
What this trial is testing

Monitoring SOF/VEL in Treatment Naïve, HCV Participants With Active Infection

Who this might be right for
Hepatitis CHIV-1-infectionLiver Diseases
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 400
Large-scale testing (Phase 3)Study completedNCT01034917
What this trial is testing

Switching From Protease Inhibitor (PI) to Etravirine in HIV-1 Infected Subjects With Viremia Suppression

Who this might be right for
HIV
Germans Trias i Pujol Hospital 43
Not applicableStudy completedNCT03416790
What this trial is testing

IMPAACT 2015 - Evaluation of the HIV-1 Reservoir in the Central Nervous System of Perinatally-Infected Youth and Young Adults With Cognitive Impairment

Who this might be right for
HIV-1-infection
International Maternal Pediatric Adolescent AIDS Clinical Trials Group 24
Not applicableStudy completedNCT00346762
What this trial is testing

Evaluating Host and Viral Factors Among HIV Infected Former Commercial Blood Donors in Fuyang, Anhui Province, China

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 186
Not applicableActive Not RecruitingNCT06773754
What this trial is testing

Fixed-Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide Taken as 5 Days Per Week

Who this might be right for
Virally Suppressed People With HIV
National Taiwan University Hospital 60
Early research (Phase 1)Study completedNCT02218125
What this trial is testing

A Phase I Study of an HIV Vaccine in Healthy, HIV Uninfected Adults

Who this might be right for
Healthy
Crucell Holland BV 25
Testing effectiveness (Phase 2)Study completedNCT00111280
What this trial is testing

TMC125-C211: Trial of TMC125 in HIV-1 Infected Subjects Who Were in a Sponsor Selected TMC125 Trial

Who this might be right for
HIV Infection
Tibotec Pharmaceuticals, Ireland 48
Early research (Phase 1)Temporarily pausedNCT06680479
What this trial is testing

Safety and Immunogenicity of Stabilized CH505 TF chTrimer Vaccination in Adults Living With HIV-1 on Suppressive Antiretroviral Therapy

Who this might be right for
HIV-1
National Institute of Allergy and Infectious Diseases (NIAID) 30
Early research (Phase 1)Study completedNCT00002403
What this trial is testing

Safety and Effectiveness of Zintevir (AR177) Given to HIV-Infected Patients

Who this might be right for
HIV Infections
Aronex Pharmaceuticals 12
Early research (Phase 1)Study completedNCT00001042
What this trial is testing

A Phase I, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Compare the Safety and Immunogenicity of Recombinant Envelope Protein rgp120/HIV-1SF2 (BIOCINE) Combined With Seven Adjuvants in Healthy HIV-1 Uninfected Individuals

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 112
Large-scale testing (Phase 3)WithdrawnNCT00686270
What this trial is testing

A Long Term Safety Study of Apricitabine in HIV-infected Patients

Who this might be right for
HIV Infections
Avexa
Not applicableStudy completedNCT01437241
What this trial is testing

Etravirine Plus 2 Analogs in HIV-infected Patients

Who this might be right for
HIV-1-infection
Hospitales Universitarios Virgen del Rocío 175
Large-scale testing (Phase 3)UnknownNCT04406727
What this trial is testing

UB-421 in Combination With Optimized Background Regimen in Patients With Multi-drug Resistant HIV-1 Infection

Who this might be right for
HIV-1 Infection
United BioPharma 50
Testing effectiveness (Phase 2)Study completedNCT00000823
What this trial is testing

Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 85
Not applicableStudy completedNCT04002323
What this trial is testing

Real Life Study of Dolutegravir Plus Lamivudine in HIV-1-Infected Treatment-Naive Patients

Who this might be right for
HIV-1-infection
University Hospital Virgen de las Nieves 88
Early research (Phase 1)Study completedNCT02362217
What this trial is testing

Assess the Safety of HIV and Hep C Vaccine Candidates When Given Separately or in Combination

Who this might be right for
Hepatitis C InfectionHIV Infection
University of Oxford 33
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation